← All work

Health tech  ·  FDA-cleared diagnostic device

The go-to-market strategy that helped validate Drawbridge Health's diagnostic device, and led to its acquisition by Thorne.

Drawbridge Health — device, GTM materials, provider and D2C campaigns

The Problem

A first-of-its-kind device. A regulated category. Buyer audiences with nothing in common.

A Thorne-backed health tech company with a first-of-its-kind diagnostic device, a regulated category, and buyer audiences ranging from clinical providers to direct-to-consumer wellness customers, each with different workflows, trust thresholds, and price sensitivities.

The Insight

Provider adoption was stalling because of workflow friction, not product quality.

Competitive assessments and client feedback loops revealed the real blocker: providers weren't hesitating because of the device's performance. They were hesitating because integrating it into their existing workflows wasn't clear enough. The work needed to address that friction directly, not just talk louder about the product.

What we did

GTM architecture across all buyer segments, built to shape the product as much as sell it.

Defined positioning and built GTM architecture across all buyer segments. Led cross-functional planning with product, sales, and engineering to align launch timing with real workflow readiness. Ran competitive assessments and client feedback loops that informed pricing strategy. Produced and executed the full marketing mix: paid channel management, promotional campaigns, in-product content, sales decks, ROI collateral, and educational materials, tailored to each audience's distinct decision-making criteria.

Positioning framework — buyer segments
Provider sales deck
D2C campaign
ROI collateral — clinical workflow
Educational materials

The Result

Sales tools addressed real clinical workflow objections, reducing friction at the point of adoption.
Market intelligence from GTM work directly influenced commercial strategy at the executive level.

A product marketing foundation that didn't just launch the device. It helped shape it. The work contributed to the market validation and commercial readiness that led Thorne HealthTech to acquire Drawbridge and fold the technology directly into their product line.

That's the clearest possible signal that the go-to-market strategy worked: the acquirer didn't just buy the product. They bought what the product had become in the market.

Recognition

Thorne HealthTech acquired Drawbridge Health and integrated the diagnostic technology directly into their product line, validating both the device and the go-to-market strategy that brought it to market.

Launching in a regulated category with multiple buyer audiences? Let's talk.

Start a conversation

Next case study

Building a trusted resource hub from zero for families navigating a rare genetic disease.